The cloning and mutagenesis market size has grown rapidly in recent years. It will grow from $3.54 billion in 2025 to $4.21 billion in 2026 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to expansion of academic research funding, growth of recombinant protein research, increasing use of genetic engineering tools, availability of standardized molecular biology kits, rise of biotech startup activity.
The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $8.5 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing demand for gene function studies, expansion of synthetic biology applications, rising investments in therapeutic protein development, growing adoption of automated lab platforms, increasing focus on precision genome editing. Major trends in the forecast period include increasing adoption of high-fidelity cloning kits, rising use of site-directed mutagenesis techniques, growing demand for crispr-based editing tools, expansion of automated molecular biology workflows, enhanced focus on reproducibility and accuracy.
The cloning and mutagenesis market is anticipated to grow due to the increasing demand for personalized medicine. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the unique characteristics of each patient. Cloning and mutagenesis play crucial roles in various aspects of personalized medicine, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. This increasing demand for personalized medicine is a significant driver of the growth in the cloning and mutagenesis market.
Leading companies in the cloning and mutagenesis markets are also actively exploring innovative techniques such as Polymerase Chain Reaction (PCR) to maintain a competitive edge. PCR is a molecular biology laboratory technique that amplifies specific DNA segments. Bio-Rad Laboratories, Inc., a US-based biotech company, launched the ID-Check Speciation Solution in April 2023. This real-time PCR method aids in meat speciation, allowing the identification of animal species in food, feed, and environmental samples. It provides a reliable and rapid means to verify raw material origins, enhancing production line cleaning processes. The solution targets mitochondrial DNA from various meat species with exceptional sensitivity, detecting DNA concentrations as low as 0.001%. It features a duplex detection system for accuracy and user convenience.
n March 2023, Sartorius AG, a Germany-based multinational life science company, acquired Polyplus Transfection SA for an undisclosed amount. Through this acquisition, Sartorius intends to broaden its upstream portfolio for cell and gene therapy manufacturing by incorporating Polyplus’s transfection reagents, nucleic acid delivery technologies, and GMP-grade plasmid DNA capabilities to support viral vector production and plasmid workflows essential to gene modification research and GMP applications. Polyplus Transfection SA, a France-based company, offers services related to cloning and mutagenesis.
Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC.
North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cloning and mutagenesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cloning and mutagenesis market by increasing costs of imported enzymes, reagents, vectors, specialized plastics, and laboratory automation components. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces cost pressure on kit manufacturing and exports. These tariffs are raising research operating costs and procurement cycles. However, they are also supporting domestic reagent production, regional supplier expansion, and localized manufacturing of molecular biology tools.
The cloning and mutagenesis market research report is one of a series of new reports that provides cloning and mutagenesis market statistics, including cloning and mutagenesis industry global market size, regional shares, competitors with a cloning and mutagenesis market share, detailed cloning and mutagenesis market segments, market trends and opportunities, and any further data you may need to thrive in the cloning and mutagenesis industry. This cloning and mutagenesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cloning and mutagenesis are integral techniques within molecular biology that involve the replication of multiple identical copies of a DNA fragment, gene, or entire genome, along with the introduction of mutations into a DNA sequence. These techniques play a crucial role in studying gene function and regulation, facilitating the development of new drugs and therapeutics, and producing recombinant enzymes and proteins.
The primary products associated with cloning and mutagenesis include cloning kits, mutagenesis kits, and other related tools. Cloning kits are specialized laboratory instruments designed to streamline the process of cloning specific DNA fragments or genes into a cloning vector. These kits are essential for various cloning experiments, including gene cloning, subcloning, site-directed mutagenesis, and library construction. Techniques such as blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, among others, are employed by academic and research institutions, biotechnology companies, and other entities engaged in molecular biology research.
The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes of sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $8.5 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing demand for gene function studies, expansion of synthetic biology applications, rising investments in therapeutic protein development, growing adoption of automated lab platforms, increasing focus on precision genome editing. Major trends in the forecast period include increasing adoption of high-fidelity cloning kits, rising use of site-directed mutagenesis techniques, growing demand for crispr-based editing tools, expansion of automated molecular biology workflows, enhanced focus on reproducibility and accuracy.
The cloning and mutagenesis market is anticipated to grow due to the increasing demand for personalized medicine. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the unique characteristics of each patient. Cloning and mutagenesis play crucial roles in various aspects of personalized medicine, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. This increasing demand for personalized medicine is a significant driver of the growth in the cloning and mutagenesis market.
Leading companies in the cloning and mutagenesis markets are also actively exploring innovative techniques such as Polymerase Chain Reaction (PCR) to maintain a competitive edge. PCR is a molecular biology laboratory technique that amplifies specific DNA segments. Bio-Rad Laboratories, Inc., a US-based biotech company, launched the ID-Check Speciation Solution in April 2023. This real-time PCR method aids in meat speciation, allowing the identification of animal species in food, feed, and environmental samples. It provides a reliable and rapid means to verify raw material origins, enhancing production line cleaning processes. The solution targets mitochondrial DNA from various meat species with exceptional sensitivity, detecting DNA concentrations as low as 0.001%. It features a duplex detection system for accuracy and user convenience.
n March 2023, Sartorius AG, a Germany-based multinational life science company, acquired Polyplus Transfection SA for an undisclosed amount. Through this acquisition, Sartorius intends to broaden its upstream portfolio for cell and gene therapy manufacturing by incorporating Polyplus’s transfection reagents, nucleic acid delivery technologies, and GMP-grade plasmid DNA capabilities to support viral vector production and plasmid workflows essential to gene modification research and GMP applications. Polyplus Transfection SA, a France-based company, offers services related to cloning and mutagenesis.
Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC.
North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cloning and mutagenesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the cloning and mutagenesis market by increasing costs of imported enzymes, reagents, vectors, specialized plastics, and laboratory automation components. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces cost pressure on kit manufacturing and exports. These tariffs are raising research operating costs and procurement cycles. However, they are also supporting domestic reagent production, regional supplier expansion, and localized manufacturing of molecular biology tools.
The cloning and mutagenesis market research report is one of a series of new reports that provides cloning and mutagenesis market statistics, including cloning and mutagenesis industry global market size, regional shares, competitors with a cloning and mutagenesis market share, detailed cloning and mutagenesis market segments, market trends and opportunities, and any further data you may need to thrive in the cloning and mutagenesis industry. This cloning and mutagenesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cloning and mutagenesis are integral techniques within molecular biology that involve the replication of multiple identical copies of a DNA fragment, gene, or entire genome, along with the introduction of mutations into a DNA sequence. These techniques play a crucial role in studying gene function and regulation, facilitating the development of new drugs and therapeutics, and producing recombinant enzymes and proteins.
The primary products associated with cloning and mutagenesis include cloning kits, mutagenesis kits, and other related tools. Cloning kits are specialized laboratory instruments designed to streamline the process of cloning specific DNA fragments or genes into a cloning vector. These kits are essential for various cloning experiments, including gene cloning, subcloning, site-directed mutagenesis, and library construction. Techniques such as blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, among others, are employed by academic and research institutions, biotechnology companies, and other entities engaged in molecular biology research.
The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes of sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cloning and Mutagenesis Market Characteristics
3. Cloning and Mutagenesis Market Supply Chain Analysis
4. Global Cloning and Mutagenesis Market Trends and Strategies
5. Cloning and Mutagenesis Market Analysis of End Use Industries
7. Global Cloning and Mutagenesis Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cloning and Mutagenesis Total Addressable Market (TAM) Analysis for the Market
9. Cloning and Mutagenesis Market Segmentation
10. Cloning and Mutagenesis Market Regional and Country Analysis
11. Asia-Pacific Cloning and Mutagenesis Market
12. China Cloning and Mutagenesis Market
13. India Cloning and Mutagenesis Market
14. Japan Cloning and Mutagenesis Market
15. Australia Cloning and Mutagenesis Market
16. Indonesia Cloning and Mutagenesis Market
17. South Korea Cloning and Mutagenesis Market
18. Taiwan Cloning and Mutagenesis Market
19. South East Asia Cloning and Mutagenesis Market
20. Western Europe Cloning and Mutagenesis Market
21. UK Cloning and Mutagenesis Market
22. Germany Cloning and Mutagenesis Market
23. France Cloning and Mutagenesis Market
24. Italy Cloning and Mutagenesis Market
25. Spain Cloning and Mutagenesis Market
26. Eastern Europe Cloning and Mutagenesis Market
27. Russia Cloning and Mutagenesis Market
28. North America Cloning and Mutagenesis Market
29. USA Cloning and Mutagenesis Market
30. Canada Cloning and Mutagenesis Market
31. South America Cloning and Mutagenesis Market
32. Brazil Cloning and Mutagenesis Market
33. Middle East Cloning and Mutagenesis Market
34. Africa Cloning and Mutagenesis Market
36. Cloning and Mutagenesis Market Competitive Landscape and Company Profiles
37. Cloning and Mutagenesis Market Other Major and Innovative Companies
40. Cloning and Mutagenesis Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cloning And Mutagenesis Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cloning and mutagenesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cloning and mutagenesis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cloning and mutagenesis market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Cloning Kits; Mutagenesis Kits; Other Products2) By Technique: Blunt End Cloning; Topo PCR Cloning; Seamless Cloning; Site-Directed Mutagenesis; Other Techniques
3) By End User: Academic and Research Institutes; Biotechnology Companies; Other End Users
Subsegments:
1) By Cloning Kits: Bacterial Cloning Kits; Yeast Cloning Kits; Viral Cloning Kits; Plasmid Cloning Kits2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits; Random Mutagenesis Kits; Error-Prone PCR Kits; CRISPR Or Cas9 Mutagenesis Kits
3) By Other Products: Enzymes; Vector Systems; Accessories
Companies Mentioned: Thermo Fisher Scientific Inc; Takara Bio Inc; Agilent Technologies Inc; New England Biolabs Inc; Merck KGaA; Promega Corporation; Bio-Rad Laboratories Inc; GenScript Biotech Corporation; Codex DNA Inc; Integrated DNA Technologies Inc; Bio-Techne Corporation; Sino Biological Inc; OriGene Technologies Inc; Bioneer Corporation; Lucigen Corporation; Inscripta Inc; Creative Biogene; Biomatik Corporation; TransGen Biotech Co Ltd; Jena Bioscience GmbH; EZBioscience; Synbio Technologies LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cloning and Mutagenesis market report include:- Thermo Fisher Scientific Inc
- Takara Bio Inc
- Agilent Technologies Inc
- New England Biolabs Inc
- Merck KGaA
- Promega Corporation
- Bio-Rad Laboratories Inc
- GenScript Biotech Corporation
- Codex DNA Inc
- Integrated DNA Technologies Inc
- Bio-Techne Corporation
- Sino Biological Inc
- OriGene Technologies Inc
- Bioneer Corporation
- Lucigen Corporation
- Inscripta Inc
- Creative Biogene
- Biomatik Corporation
- TransGen Biotech Co Ltd
- Jena Bioscience GmbH
- EZBioscience
- Synbio Technologies LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.21 Billion |
| Forecasted Market Value ( USD | $ 8.5 Billion |
| Compound Annual Growth Rate | 19.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
